These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2455204

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Preliminary clinic observation on the inhibition of HBV by receptor-targeted drug L-HSA-AraAMP].
    Wang H, Zhang L, Wang X.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):12-4. PubMed ID: 12515162
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
    Guardia J, Esteban R, Buti M, Jardí R, Allende H, Esteban JI.
    Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B.
    Buti M, Rodriguez-Frias F, Genesca J, Arranz A, Jardi R, Esteban R, Guardia J.
    Liver; 1993 Jun; 13(3):136-40. PubMed ID: 7687734
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
    Torrani Cerenzia MR, Fiume L, Busi C, Mattioli A, Di Stefano G, Gervasi GB, Brunetto MR, Piantino P, Verme G, Bonino F.
    J Hepatol; 1994 Feb; 20(2):307-9. PubMed ID: 7516363
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH, Davis GL, Hanson RG, Pappas SC, Peters MG, Avigan MI, Waggoner JG, Howard R, Jones EA, Straus SE.
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.
    Fiume L, Mattioli A, Busi C, Accorsi C.
    Gut; 1984 Dec; 25(12):1392-8. PubMed ID: 6210232
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Nephrol Dial Transplant; 1994 Dec; 9(7):820-3. PubMed ID: 7526277
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C, Ouzan D, Fontanges T, Chevallier M, Chossegros P, Degos F, Chevallier P, Hantz O.
    J Hepatol; 1986 Dec; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.